References
- Lyon AR, Bossone E, Schneider B, Sechtem U, Citro R, Underwood SR, et al. Current state of knowledge on Takotsubo syndrome: a position statement from the taskforce on Takotsubo syndrome of the heart failure association of the European Society of Cardiology. Eur J Heart Fail. 2016 Jan;18(1):8-27.
- Medina de Chazal H, Del Buono MG, Keyser-Marcus L, Ma L, Moeller FG, Berrocal D, et al. Stress cardiomyopathy diagnosis and treatment: JACC state-of-the-art review. J Am Coll Cardiol. 2018 Oct 16;72(16):1955-1971.
- Akashi YJ, Nef HM, Lyon AR. Epidemiology and pathophysiology of Takotsubo syndrome. Nat Rev Cardiol. 2015;12:387-97.
- Halvorsen S, Mehilli J, Cassese S, Hall TS, Abdelhamid M, Barbato E, et al. 2022 ESC guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery. Eur Heart J. 2022 Oct 14;43(39):3826-3924.
- Ohe H, Hoshino J, Ozawa M. Factors affecting outcomes of liver transplantation: an analysis of OPTN/UNOS database. Clin Transpl. 2011:953.
- Patel K, Bhatti S, Black S. Predisposing factors and health-care utilization in liver transplant recipients with Takotsubo cardiomyopathy: a national analysis. Ibnosina J Med Biomed Sci. 2020;12:300-6.
- Zmaili M, Alzubi J, Alkhayyat M, Cohen J, Alkharabsheh S, Rana M, et al. Takotsubo cardiomyopathy in orthotopic liver transplant recipients: a cohort study using multi-center pooled electronic health record data. World J Hepatol. 2022 Feb 27;14(2):400-410.
- Rawashdeh B, Yaghmour N, Sulieman D, Abuassi M, Cooper M. Takotsubo cardiomyopathy after solid organ transplantation: a scoping review. Ann Med Surg (Lond). 2024 Apr 3;86(5):2883-2891.
- Hall EC, Boyarsky BJ, Deshpande NA, Garonzik-Wang JM, Berger JC, Dagher NN, et al. Perioperative complications after live-donor hepatectomy. JAMA Surg. 2014 Mar;149(3):288-91.
- Yankol Y, Mecit N, Kanmaz T, Kalayoğlu M, Acarlı K. Complications and outcomes of 890 living liver donor hepatectomies at a single center: risks of saving a loved one’s life. Turk J Surg. 2020 Jun 8;36(2):192-201.
- Singh T, Khan H, Gamble D, et al. Takotsubo syndrome: pathophysiology, emerging concepts and clinical implications. Circulation. 2022;145:1002.
- Citro R, Okura H, Ghadri JR, et al; EACVI Scientific Documents Committee. Multimodality imaging in Takotsubo syndrome: a joint consensus document of the European Association of Cardiovascular Imaging (EACVI) and the Japanese Society of Echocardiography (JSE). Eur Heart J Cardiovasc Imaging. 2020 Oct 20;21(11):1184-1207.
- Eitel I, et al. Clinical characteristics and cardiovascular magnetic resonance findings in stress (Takotsubo) cardiomyopathy. JAMA. 2011;306:277-86.
- Lisi E, Guida V, Blengino S, Pedrazzi E, Ossoli D, Parati G. Intra-aortic balloon pump for treatment of refractory ventricular tachycardia in Takotsubo cardiomyopathy: a case report. Int J Cardiol. 2014;174:135-6.
- Rashed A, Won S, Saad M, Schreiber T. Use of the Impella 2.5 left ventricular assist device in a patient with cardiogenic shock secondary to Takotsubo cardiomyopathy. BMJ Case Rep. 2015;2015:1-4.
- Yoshioka T, Hashimoto A, Tsuchihashi K, et al. Clinical implications of midventricular obstruction and intravenous propranolol use in transient left ventricular apical ballooning (Takotsubo cardiomyopathy). Am Heart J. 2008;155:1-7.
- Bonacchi M, Maiani M, Harmelin G, Sani G. Intractable cardiogenic shock in stress cardiomyopathy with left ventricular outflow tract obstruction: is extra-corporeal life support the best treatment? Eur J Heart Fail. 2009;11:721-7.
- Scally C, Rudd A, Mezincescu A, et al. Persistent long-term structural, functional, and metabolic changes after stress-induced (Takotsubo) cardiomyopathy. Circulation. 2018;137:1039-48.
- Santoro F, Ieva R, Musaico F, et al. Lack of efficacy of drug therapy in preventing Takotsubo cardiomyopathy recurrence: a meta-analysis. Clin Cardiol. 2014;37:434-9.